In a Galaxy too close to Home for Comfort

September, 13, 2021 | 3 Comments


  1. Crusoe – but life got serious…

    Shipwreck of the Singular

    15: Crusoe we say was rescued

    Almost ready for lift-off! Meet the crew aboard SpaceX’s first all-civilian orbital mission

    The billionaire, who is described as an accomplished jet pilot, said: “I truly want us to live in a world 50 or 100 years from now where people are jumping in their rockets like the Jetsons and there are families bouncing around on the moon with their kid in a spacesuit.

    “I also think if we are going to live in that world, we better conquer childhood cancer along the way,” Mr Isaacman added.

    Branson, Bezos, Musk: The billionaire space race but what’s in it for us?

    Solving the big problems of life is safer in their hands than in the hands we are dealt on planet earth –

    Shipwreck of the Singular

    Where she said hushed
    Were the adults

    Being Done-For, The ‘Milky’ Way…

  2. A different kind of trip on planet earth being rolled out in Europe Scandinavia and ultimately across the globe.

    September 16, 2021

    Awakn Life Sciences to Acquire Leading Ketamine-assisted Psychotherapy Clinic in Norway
    Launches Nordics Regional Expansion

    Dr. Lowan Stewart, One of Europe’s Preeminent Ketamine Physicians, Appointed as Awakn’s Regional Director for the Nordics

    TORONTO, September ##, 2021 – Awakn Life Sciences Corp. (“Awakn” or the “Company”)), (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) a biotechnology company developing and delivering psychedelic medicine to treat addiction, is pleased to announce that it has signed a binding share exchange agreement to acquire a 100% interest in Axonklinikken AS (“Axon”), a leading ketamine-assisted psychotherapy clinic in Norway. As part of the transaction Axon will be renamed ‘Awakn Oslo AS’, and Axon’s majority shareholder Dr. Lowan Stewart will be appointed as Regional Director for the Nordics and Managing Director Awakn Oslo AS.

    The acquisition will enable Awakn to accelerate its clinic roll out program, as Awakn will now parallel path its regional expansion plans in both the Nordics (Norway, Sweden, Denmark, Finland and Iceland) and U.K. & Ireland, territories with a combined 100m population and US$5trn GDP.

    Awakn Oslo AS will serve as a regional hub from which Awakn plans to expand across the Nordics and is in addition to the two other clinics Awakn plans to have operational this fiscal year (Bristol and London locations), all of which Awakn expects to begin generating revenue in the near-term.

    “This is a key element of our goal for Awakn to become the leading authority in the development and delivery of psychedelic therapeutics to treat addiction,” said Anthony Tennyson, Awakn’s CEO. “Our approach of development and delivery enables Awakn to earn revenue while we also develop a deep IP portfolio with strong commercial potential. This acquisition will enable Awakn to accelerate the first element of our three-pronged revenue generation strategy: clinics in the UK and Europe, licencing partnership beyond the UK and Europe, and therapeutics commercialisation.”

Leave a Reply